An equilibrium-type competitive-binding fluorescence immunoassay with high sensitMty and excellent precision is described that obviates separation of free from bound label. In the assay relatively large (10 m diameter) antibodycoated non-fluorescent particles and very small (0.10 m diameter) antigen-coated fluorescent latex particles are used. Soluble nonlabeled antigen competes with antigen on the microspheres for antibody binding sites on the larger spheres. After equilibrium is attained, the fluorescence distribution of 5000 of the large spheres is measured in a flow cytometer. The mean values for the fluorescence distribution obtained from samples containing known concentrations of soluble antigen are used to construct a standard displacement curve. In a prototype assay for the antigen horseradish peroxidase, a sensitivity of 10-12 moIfL has been achieved. Undiluted serum can be assayed without loss of sensitivity. Preliminary experiments also indicate that double-antibody "sandwich"-type assays of very high sensitivity (10_14 mol/L) are also possible when this dual-sphere concept is exploited. and washing steps. The gating of fluorescence on scattered light pulses allows the selective measurement of particle-associated fluorescence. A prototype assay for human IgG, performed in a 10-fold diluted serum matrix, achieved a sensitivity of 6 x 10_li mol/L (4).
short light-pulseand measurement of fluorescence is started after enough time has elapsed for the background (as in serum) to decay to zero. A sensitivity of 10b0 mol/L for human immunoglobulin G (IgG) has been obtained (3). 1 The other approach is a "sandwich"-type fluorescence immunoassay in which antibody-coated microspheres, sample, and soluble fluorescent antibody are reacted together as in a conventional "sandwich" immunoassay. Laser flow-cytometry obviates separation and washing steps. The gating of fluorescence on scattered light pulses allows the selective measurement of particle-associated fluorescence. A prototype assay for human IgG, performed in a 10-fold diluted serum matrix, achieved a sensitivity of 6 x 10_li mol/L (4).
We have used a novel concept which takes advantage of both flow cytometi-y (5) and amplified immunomicrosphere technologies (6) . Our approach is to use relatively large nonfluorescent microspheres (10 pm in diameter) as an antibody carrier and very small fluorescent microspheres (0.10 pm in diameter) as either an antigen carrier (for a competitive binding assay) or an antibody carrier (for a "sandwich"-type assay). The use of this amplified fluorescent carrier has resulted in exquisite sensitivity in prototype competitive binding (10-12 mol/L) and "sandwich" (10' mol/L) assays.
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Materials and Methods

Reagents
Apparatus
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Preliminary experiments showed that nonspecific bead interactions couldbe prevented by using buffers containing high concentrations of protein (at least 20 g/L) or whole serum, or both. To generate the data for the prototype system presented herein, we chosea 50 gIL BSA buffer. In one experiment we used whole rabbit serum. The ratio of fluorescentAg-coated particles to Ab-coated particles in a 1-mL reaction volume that yielded a 60% mpximum saturation (in the absenceoffree Ag) at equilibrium was found to be 30000:1. The time required for equilibrium to occurat this ratio was 12 to 14 h. The binding of Ag-coated small particles to Ab-coatedlarge particles is illustrated in Figure   2 . Figure 3a illustrates the shape and dynamic range of twostep displacement curves. The sensitivity of the assay has consistently been 10-12 mol/L, which for the 1-mL reaction volume we usedtranslates to 10-15 mol of analyte. Singlestep and two-step displacement curves are compared in Figure 3b . Although the two-step processes reportedly (10) increase the sensitivity of competitive-binding radioimmunoassays of protein by factors two-to fourfold, we saw virtually no difference in sensitivity between these two typesof assay procedures. Figure 3cillustrates both reagent stability and assay performance when whole rabbit serum (instead of BSA buffer) is used as the vehicle for the HRP dilutions. This two-step curve, generated with immunobead reagents prepared one year previously,is practically identical in shape to those in Figures 3a and b. The dynamic range of the assay can be manipulated by altering the diameter of the Ab-coated carrier within the range of 2 to 15 pm. For example, Figure 3d illustrates the compression in dynamic range that results when Ab-coated spheres 3 pm in diameter are used instead of 10-pm spheres. Presumably, the dynamic range also could be adjusted by altering such variables as Ag and Ab immunobead ratios or by adjusting the amounts of Ab and Ag used to coat the particles. Both within-assay and between-assay precision have been excellent (Table 1) .
CHANNEL NUMBER
The sensitivity and stability of the fluorescence detection system, along with the hydrodynamic focusing principle used in the design of flow cytometers, make this assay both possible and practical. Indeed, hydrodynamic focusing, which creates an extremely narrow sample stream (10 to 15 pm diameter) with the resulting very small probe volumes (6 pL) (11) is largely responsible for the separation-free HRP, mol/L feature of this assay; there are fewer than 20 free 0.1-/.Ini diameter spheres present in the probe volume at any time.
The small probe volume should also diminish or eliminate problems caused by sample contaminants such as bilirubin, which because of their spectral properties reportedly interfere with fluoroimmunoassays (12). Also, ac coupling of thE fluorescence-amplifying electronics, together with the abii. ty to trigger on the light scatter of the large sphere, allowt the detection electronics to ignore the small dc fluorescence originating from the steady-state concentration of free beade and other fluorescent molecules, and to record only that associated with the relatively large (10-pm) particles at they pass through the probe volume. The absence of a separation step both facilitates the mechanics of the assay and improves precision because of the maintenance ol equilibrium conditions throughout the measurement proc. ess.
The relatively long(12 h) incubationtimes in the two-step assay allow complete equilibrium of the very low antigen concentrationswith antibody. However, in some more recent experiments (Figure 3b ) we found that a one-step incubation (soluble and labeled Ag added at the same time of 14 h does not perceptibly affect assay sensitivity.
To our knowledge, this report represents the first use of a flow cytometer in a competitive-binding immunoassay, However, as described in the introduction, a flow-cytometric fluorescence sandwich-type assay for human immunoglobulin has been reported. This assay used anti-human IgGcoated 1-5-pm microspheres, 40-50-pm polyacrylamide beads, or 30-40-pm dextran beads. Soluble, fluorescencelabeled antibodyto human IgG was used as the second piece of'bread" in the sandwich. No separation of free from bound label was required, for the same reasons explained above, The matrix for the assay was diluted serum; the reproducible sensitivity was 10 ng/mL, or about 6 x 10_li molJL.
Our initial efforts to use the big bead-little bead concept for a sandwich assay have been successful. We coated both the 10-pm non-fluorescent and fluorescent 0.10-pm particleswith the same HRP-Ab used in the competitive-binding model. In a two-step preliminary experiment, the assay sensitivity was 10-14 mol/L (Figure 4) .
The usefulness of this dual-sphere amplified immunoas#{149} say in the real world of clinical samples (usually whole serum) remains to be tested. Our limited data on using rabbit serum as a reaction matrix is at least encouraging is that assay sensitivity was not degraded. However, only the thorough testing of hundreds of human serum samples can bring to light potential interferences. In other bead-based assays (notably PACIA, 13), aggregation of particles by factors in serum such as rheumatoid factor was prevented by using F(ab')2 antibody fragments to coat the particles, Assay sensitivity for the competitive binding model appeart to be well within the range of most analytes of clinical interest. If the added 100-fold increase in sensitivity oh. and limited data-acquisition requirements, should be considerably less expensive than those currently marketed. An automated device is feasible.
